Skip to content

David Kirn, Director at 4D Molecular Therapeutics, sold FDMT on Jul 10, 2026

Data as of Oct 16

▼ SELL$5.7K442 shares at $12.84David Kirn DirectorFDMT 4D Molecular Therapeutics, Inc.
Watch FDMT
Traded
Jul 10, 2026
Disclosed
Jul 14, 2026
Filed
4 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

David Kirn, Director at 4D Molecular Therapeutics, sold FDMT on Jul 10, 2026TRADEDDISCLOSED
FDMTSimilar stocks (XLV — its sector index fund), rebased to FDMT's price on the disclosure day
FDMT since disclosure
+3.8%
after the sale
Similar stocks (XLV) since disclosure
+11.6%
XLV — its sector index fund

Change in closing price from Jul 14, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLDavid Kirn DirectorFDMT 4D Molecular Therapeutics, Inc.$184Kdisclosed Jul 14 · filed 4 days after the trade
  2. ▼ SELLDavid Kirn DirectorFDMT 4D Molecular Therapeutics, Inc.$548Kdisclosed Jul 14 · filed 5 days after the trade · late

See every trade on FDMT →